Cabozantinib S-malate

CAS: 1140909-48-3

Ref. TM-T1797

Produktinformation

• Name: Cabozantinib S-malate
• Synonyme: Cabozantinib, XL184, Cabozantinib Malate, (2S)-2-Hydroxybutanedioic acid compd.with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide(1:1), (2S)-2-hydroxybutanedioic acid, Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4- quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1), Cabozantinib L-(-)-Apple Acid, Cabozantinib L-Malate, Cabozantinib Malate, Cometriq, N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide mono[(2S)-2-hydroxybutanedioate], N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, Xl 184
• CAS: 1140909-48-3

Beschreibung

Cabozantinib S-malate (XL184) is the s-malate salt form of cabozantinib, an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 635.59
• Formel: C₃₂H₃₀FN₃O₁₀
• Reinheit: 100%
• Farbe/Form: Solid
• InChl: InChI=1S/C28H24FN3O5.C4H6O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18;5-2(4(8)9)1-3(6)7/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34);2,5H,1H2,(H,6,7)(H,8,9)
• InChI Key: InChIKey=HFCFMRYTXDINDK-UHFFFAOYSA-N
• SMILES: COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC.O=C(O)CC(O)C(=O)O